ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



Bing-Neel syndrome as a rare neurological complication of Waldenström macroglobulinemia: A case report

Ali Salbas.



Abstract
Download PDF Cited by 0 ArticlesPost

Waldenström macroglobulinemia (WM) is a lymphoproliferative disorder characterized by lymphoplasmacytic infiltration and Immunoglobulin M (IgM) monoclonal gammopathy. Bing-Neel syndrome (BNS), a rare complication of WM, arises from direct infiltration of malignant lymphoplasmacytic cells into the central nervous system (CNS). This report presents a 66-year-old female patient who developed BNS 15 years after the initial diagnosis of WM. The patient presented with neurological symptoms including dizziness, imbalance, memory impairment, and speech disturbances. Brain magnetic resonance imaging (MRI) revealed leptomeningeal and dural enhancement accompanied by vasogenic edema. Laboratory findings showed IgM lambda monoclonal gammopathy and lymphoplasmacytic infiltration. Although histopathological confirmation could not be obtained, the clinical and radiological findings supported the diagnosis of BNS. Following treatment with a combination chemotherapy regimen of rituximab and bendamustine (R-BENDA), along with high-dose methotrexate, clinical and radiological regression was observed. This case highlights that BNS may develop years after the initial diagnosis of WM and should be considered in the differential diagnosis.

Key words: Bing-Neel syndrome; Waldenström macroglobulinemia; central nervous system; magnetic resonance imaging; case report







Bibliomed Article Statistics

35
135
36
44
36
37
31
R
E
A
D
S

17

28

17

34

26

13

11
D
O
W
N
L
O
A
D
S
06070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.